<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41904">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01961024</url>
  </required_header>
  <id_info>
    <org_study_id>ES-0006</org_study_id>
    <nct_id>NCT01961024</nct_id>
  </id_info>
  <brief_title>Postprandial VLDL-TG Metabolism</brief_title>
  <official_title>Postprandial VLDL-TG Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In thise study, we aim to determine the effect of meal fat on VLDL-TG kinetics in type 2
      diabetic and healthy subjects matched for BMI in order to elucidate the potential
      pathophysiological differences in VLDL-TG FA channeling towards oxidation and storage in
      abdominal and leg subcutaneous adipose tissue. Specifically, we want to measure, by way of
      fat and muscle biopsies, the quantitative postprandial storage of VLDL-TG FA's in skeletal
      muscle and adipose tissue in relation to a series of tissue specific proteins and enzymes
      that might be involved in regulating skeletal muscle and adipose tissue FA storage.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>VLDL-TG storage in adipose tissue</measure>
    <time_frame>3 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>18F-THA fractional storage</measure>
    <time_frame>6 Hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Type 2 diabetic men</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Age- and weight-matched controls</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      specimen of muscle specimen of adipose tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Males with diabetes from the department´s out-patient clinic. Control group of healthy
        volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written consent

        Exclusion Criteria:

          -  Known diseases

          -  Alcohol abuse

          -  Smoker

          -  Regular use of medicine
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Esben Søndergaard, MD, PhD</last_name>
    <phone>+4578461631</phone>
    <email>esbens@dadlnet.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Endocrinology MEA, Aarhus Hospital</name>
      <address>
        <city>Aarhus C</city>
        <state>Please Select</state>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>4528730943</phone>
    </contact>
    <investigator>
      <last_name>Esben Søndergaard, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 10, 2013</lastchanged_date>
  <firstreceived_date>September 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Esben Søndergaard</investigator_full_name>
    <investigator_title>Post Doc, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>VLDL-TG kinetics</keyword>
  <keyword>Postprandial state</keyword>
  <keyword>Obesity</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
